Page last updated: 2024-11-05

ticlopidine and Livedo Reticularis And Cerebrovascular Accidents

ticlopidine has been researched along with Livedo Reticularis And Cerebrovascular Accidents in 2 studies

Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Flöel, A1
Imai, T1
Lohmann, H1
Bethke, F1
Sunderkötter, C1
Droste, DW1
Wohlrab, J1
Fischer, M1
Marsch, WC1

Reviews

1 review available for ticlopidine and Livedo Reticularis And Cerebrovascular Accidents

ArticleYear
[Current therapy of Sneddon's syndrome].
    Deutsche medizinische Wochenschrift (1946), 2001, Jun-22, Volume: 126, Issue:25-26

    Topics: Alprostadil; Antihypertensive Agents; Blood Circulation; Captopril; Fibrinolytic Agents; Humans; Pro

2001

Other Studies

1 other study available for ticlopidine and Livedo Reticularis And Cerebrovascular Accidents

ArticleYear
Therapy of Sneddon syndrome.
    European neurology, 2002, Volume: 48, Issue:3

    Topics: Adult; Antibodies, Antiphospholipid; Anticonvulsants; Aspirin; Azathioprine; Clopidogrel; Drug Thera

2002